How much does Delamanid medical insurance cost?

Delamanid is a drug used to treat tuberculosis under the brand name Deltyba. Specifically, it is used along with other anti-tuberculosis drugs to treat active multidrug-resistant tuberculosis. Delamanid works by blocking the production of mycolic acid and thereby destabilizing the bacterial cell wall. It belongs to the nitroimidazole class of drugs.

Delamanid is an anti-tuberculosis drug derived from nitrodihydroimidazole compounds that inhibit the synthesis of mycolic acid in the bacterial cell wall1. It is used in combination regimens to treat multidrug-resistant and extensively drug-resistant tuberculosis (TB). The emergence of multidrug-resistant and extensively drug-resistant tuberculosis poses clinical challenges for patients, as the disease is associated with higher mortality and inadequate treatment response to standardized antituberculous therapy with isoniazid and rifampicin. It is generally taken orally. As of 2016, no pregnancy studies have been conducted on it. Common side effects include headache, dizziness and nausea. Other side effects include QT prolongation.

The original drug Delamani has been launched in China and is included in the scope of Class B medical insurance. Reimbursement is limited to patients with multi-drug-resistant tuberculosis. Specifications The price of each box of 50mg*60 tablets may be more than 6,000 yuan. The reimbursement ratio is different in different regions, and the price after reimbursement is also different. For specific medical insurance reimbursement, please consult the local medical insurance bureau and other places. The price of the Russian version of the original drug Dramani, 50mg*48 tablets, sold overseas may be around RMB 1,000-2,000 per box (the price may fluctuate due to the exchange rate). There is currently no generic version of Dramani available on the market. For more drug information and specific prices, please consult Yaode’s medical consultant.